J Bone Metab.
2014 Feb;21(1):76-83.
Two Cases of Hypophosphatemic Osteomalacia After Long-term Low Dose Adefovir Therapy in Chronic Hepatitis B and Literature Review
- Affiliations
-
- 1Department of Intermal Medicine, Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea. mdkim9111@dsmc.or.kr
- 2Department of Pathology, Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
Abstract
- Adefovir dipivoxil (ADV) is a nucleotide used as long-term therapy of chronic hepatitis B. Many published reports have shown that long-term high-dose therapy with adefovir can be associated with proximal renal tubular dysfunction resulting in significant hypophosphatemia, renal insufficiency and osteomalacia. We have encountered two patients who developed evidence of hypophosphatemic osteomalacia while on long-term low-dose adefovir therapy for chronic hepatitis B. We report on its clinical features and its potential resolution with cessation of the drug and supplementation with phosphate. We also reviewed the other published cases associated with hypophosphatemic osteomalacia after low-dose adefovir therapy. The symptoms and the hypophosphatemia improved after cessation of the drug and supplementation with phosphate in most cases. Patients taking adefovir long-term should receive regular investigation of the phosphate level and renal function.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Three Cases of Osteomalacia with Fractures Induced by Adefovir in Chronic Hepatitis B
- An Uncommon Case of Bilateral Pathologic Hip Fractures: Antiviral Drug-induced Osteomalacia in a Patient with Hepatitis B
- A case of hypophosphatemic osteomalacia associated with low-dose adefovir dipivoxil treatment
- Recalcitrant Low Back Pain Diagnosed as Hypophosphatemic Osteomalacia Induced by Antiviral Medication
- A Case of Osteomalacia Related to Adefovir in a Patient with Chronic Hepatitis B
